Distinct Hybrid Hydrates of Paritaprevir: Combined
Experimental and Computational Assessment of their Hydration–Dehydration
Behavior and Implications for Regulatory Controls
posted on 2021-12-16, 02:13authored byRichard
S. Hong, Rajni Miglani Bhardwaj, Rodger Henry, Alessandra Mattei, Moiz Diwan, Albert Thomas, Gerald D. Danzer, Ahmad Y. Sheikh
Paritaprevir is a first-generation
direct-acting antiviral and,
as a conformationally flexible molecule containing a 15-membered macrocyclic
ring, has unique chameleonic and solid-state features. The two commercially
relevant forms (Forms I and II) are clearly differentiated wherein
Form I benefits from strong intermolecular interactions, whereas weaker
intermolecular interactions in Form II are partially compensated by
the energetic advantage of an intramolecular hydrogen bond, which
significantly lowers the conformational energy. Both forms are hydrated
and exhibit hybrid features of stoichiometric and nonstoichiometric
hydrates, albeit differently. Form I exhibits strong host–host
and weak host–water interactions and contains stable channels
that do not substantially change upon hydration/dehydration. Form
II contains weak host–host and strong host–water interactions
and a host–water hydrogen bonding planar network that evolves
with the hydration state. Furthermore, periodic density functional
theory calculations for potential energy differences show that a transition
from enthalpic stabilization of the structure to entropic stabilization
occurs at 2.5 mol equiv of water in Form II. Since the paritaprevir
drug substance is manufactured as Form II, implications of its features
for nomenclature and testing within the regulatory context are also
discussed.